ADAMTS13 and thrombotic thrombocytopenic purpura: The clinical relevance of reduced ADAMTS13 is well known from a disease termed TTP in which the formation of ULVWF multimers due to reduced ADAMTS13 leads to thrombocytopenia, hemolysis, AKI, and (often severe) neurological symptoms.